Article
Mutant induced neurons and humanized mice enable identification of Niemann-Pick type C1 proteostatic therapies
29 Aug 2024
Abstract excerpt
Therapeutics that rescue folding, trafficking, and function of disease-causing missense mutants are sought for a host of human diseases, but efforts to leverage model systems to test emerging strategies have met with limited success. Such is the case for Niemann-Pick type C1 disease, a lysosomal disorder characterized by impaired intracellular cholesterol trafficking, progressive neurodegeneration, and early...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
